165 related articles for article (PubMed ID: 33580203)
1. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.
Rapaport F; Neelamraju Y; Baslan T; Hassane D; Gruszczynska A; Robert de Massy M; Farnoud N; Haddox S; Lee T; Medina-Martinez J; Sheridan C; Thurmond A; Becker M; Bekiranov S; Carroll M; Moses Murdock H; Valk PJM; Bullinger L; D'Andrea R; Lowe SW; Neuberg D; Levine RL; Melnick A; Garrett-Bakelman FE
Leukemia; 2021 Sep; 35(9):2688-2692. PubMed ID: 33580203
[No Abstract] [Full Text] [Related]
2. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
3. WT1 - Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant.
Sperotto A; Gottardi M; Candoni A; Toffoletti E; De Marchi R; Petruzzellis G; Pizzano U; Fanin R
Leuk Res; 2021 Sep; 108():106587. PubMed ID: 34020318
[No Abstract] [Full Text] [Related]
4. Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia.
Calvello C; Rocca B; Klersy C; Zappatore R; Giardini I; Dambruoso I; Pasi F; Caresana M; Zappasodi P; Nano R; Boni M; Bernasconi P
Leuk Lymphoma; 2018 Mar; 59(3):702-709. PubMed ID: 28679326
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
6. Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients.
Zhao J; Gu L; Li C; Ma W; Ni Z
Tumour Biol; 2014 Jul; 35(7):6919-24. PubMed ID: 24737589
[TBL] [Abstract][Full Text] [Related]
7. Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction.
Xiong Q; Huang S; Li YH; Lv N; Lv C; Ding Y; Liu WW; Wang LL; Chen Y; Sun L; Zhao Y; Liao SY; Zhang MQ; Zhu BL; Yu L
Oncol Rep; 2020 Apr; 43(4):1278-1288. PubMed ID: 32323795
[TBL] [Abstract][Full Text] [Related]
8. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
[TBL] [Abstract][Full Text] [Related]
9. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
10. Can chemotherapy cause cancer relapse?
Cancer Discov; 2012 Mar; 2(3):OF4. PubMed ID: 22586001
[TBL] [Abstract][Full Text] [Related]
11. PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.
Al Hinai ASA; Grob T; Rijken M; Kavelaars FG; Zeilemaker A; Erpelinck-Verschueren CAJ; Sanders MA; Löwenberg B; Jongen-Lavrencic M; Valk PJM
Leukemia; 2021 Sep; 35(9):2693-2697. PubMed ID: 33589749
[No Abstract] [Full Text] [Related]
12. The prognostic potential of monitoring disease dynamics in NPM1-positive acute myeloid leukemia.
Hoffmann H; Thiede C; Glauche I; Kramer M; Röllig C; Ehninger G; Bornhäuser M; Roeder I
Leukemia; 2019 Jun; 33(6):1531-1534. PubMed ID: 30675011
[No Abstract] [Full Text] [Related]
13. Evolutionary trajectory of leukemic clones and its clinical implications.
Tuval A; Shlush LI
Haematologica; 2019 May; 104(5):872-880. PubMed ID: 31004016
[TBL] [Abstract][Full Text] [Related]
14. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
[TBL] [Abstract][Full Text] [Related]
16. Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.
Cappelli LV; Meggendorfer M; Baer C; Nadarajah N; Hutter S; Jeromin S; Dicker F; Kern W; Haferlach T; Haferlach C; Höllein A
Leukemia; 2022 Feb; 36(2):394-402. PubMed ID: 34376804
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.
Pallavajjala A; Kim D; Li T; Ghiaur G; Jones RJ; Burns KH; Salzberg SL; Ning Y
Leuk Lymphoma; 2018 May; 59(5):1231-1238. PubMed ID: 28882084
[TBL] [Abstract][Full Text] [Related]
18. Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
Garrido-Castro AC; Winer EP
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376163
[No Abstract] [Full Text] [Related]
19. The clinical relevance of BAALC and ERG expression levels in pediatric AML.
Hermkens MC; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Baruchel A; Stary J; Reinhardt D; Zimmerman M; de Haas V; Pieters R; Zwaan CM
Leukemia; 2013 Mar; 27(3):735-7. PubMed ID: 22895118
[No Abstract] [Full Text] [Related]
20. Getting a handle on hereditary CEBPA mutations.
DiNardo CD
Blood; 2015 Sep; 126(10):1156-8. PubMed ID: 26337351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
